These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9057742)

  • 1. Miltefosine in recurrent cutaneous breast cancer.
    Clive S; Leonard RC
    Lancet; 1997 Mar; 349(9052):621-2. PubMed ID: 9057742
    [No Abstract]   [Full Text] [Related]  

  • 2. Loco-regional control of cutaneous metastases of malignant melanoma by treatment with miltefosine (Miltex).
    Ragnarsson-Olding B; Djureen-Mårtensson E; Månsson-Brahme E; Hansson J
    Acta Oncol; 2005; 44(7):773-7. PubMed ID: 16227173
    [No Abstract]   [Full Text] [Related]  

  • 3. [[Treatment with Miltex for metastatic skin lesions in breast cancer] ].
    Moĭseenko VM; Orlova RV; Ermakova NA; Protsenko SA
    Vopr Onkol; 2000; 46(5):600-3. PubMed ID: 11202195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized, double-blind, placebo-controlled, multicenter trial of 6% miltefosine solution, a topical chemotherapy in cutaneous metastases from breast cancer.
    Leonard R; Hardy J; van Tienhoven G; Houston S; Simmonds P; David M; Mansi J
    J Clin Oncol; 2001 Nov; 19(21):4150-9. PubMed ID: 11689583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hexadecylphosphocholine in the topical treatment of skin metastases in breast cancer patients.
    Unger C; Peukert M; Sindermann H; Hilgard P; Nagel G; Eibl H
    Cancer Treat Rev; 1990 Sep; 17(2-3):243-6. PubMed ID: 2272039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of cutaneous metastases of a squamous cell carcinoma of the leg with topical miltefosine].
    Mahieu-Renard L; Richard MA; Dales JP; Buscaylet S; Lagrassa S; Grob JJ
    Ann Dermatol Venereol; 2005 Apr; 132(4):346-8. PubMed ID: 15886562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Miltefosine as a topical treatment for cutaneous metastases in breast carcinoma.
    Clive S; Gardiner J; Leonard RC
    Cancer Chemother Pharmacol; 1999; 44 Suppl():S29-30. PubMed ID: 10602908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II trial of topically applied miltefosine solution in patients with skin-metastasized breast cancer.
    Terwogt JM; Mandjes IA; Sindermann H; Beijnen JH; ten Bokkel Huinink WW
    Br J Cancer; 1999 Mar; 79(7-8):1158-61. PubMed ID: 10098751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Miltefosine: new preparation. Solution for cutaneous application.
    Prescrire Int; 1998 Feb; 7(33):5-6. PubMed ID: 10183390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase II trial of miltefosine in patients with cutaneous T-cell lymphoma.
    Dumontet C; Thomas L; Bérard F; Gimonet JF; Coiffier B
    Bull Cancer; 2006 Nov; 93(11):E115-8. PubMed ID: 17145574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hexadecylphosphocholine (D 18506) in the topical treatment of skin metastases: a phase-I trial.
    Unger C; Eibl H; Breiser A; von Heyden HW; Engel J; Hilgard P; Sindermann H; Peukert M; Nagel GA
    Onkologie; 1988 Dec; 11(6):295-6. PubMed ID: 3071766
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of vindesine in lymphangitic-type cutaneous recurrence of breast cancer].
    Palangie T; Jouve M; Giralt E; Bretaudeau B; Pouillart P
    Bull Cancer; 1983; 70(5):437-8. PubMed ID: 6582941
    [No Abstract]   [Full Text] [Related]  

  • 13. Hexadecylphosphocholine, a new ether lipid analogue. Studies on the antineoplastic activity in vitro and in vivo.
    Unger C; Damenz W; Fleer EA; Kim DJ; Breiser A; Hilgard P; Engel J; Nagel G; Eibl H
    Acta Oncol; 1989; 28(2):213-7. PubMed ID: 2736110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hexadecylphosphocholine in the topical treatment of skin metastases in breast cancer patients.
    Unger C; Sindermann H; Peukert M; Hilgard P; Engel J; Eibl H
    Prog Exp Tumor Res; 1992; 34():153-9. PubMed ID: 1438798
    [No Abstract]   [Full Text] [Related]  

  • 15. Phase II study of miltefosine 6% solution as topical treatment of skin metastases in breast cancer patients.
    Smorenburg CH; Seynaeve C; Bontenbal M; Planting AS; Sindermann H; Verweij J
    Anticancer Drugs; 2000 Nov; 11(10):825-8. PubMed ID: 11142690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrochemotherapy for large cutaneous recurrence of breast cancer: a phase II clinical trial.
    Matthiessen LW; Johannesen HH; Hendel HW; Moss T; Kamby C; Gehl J
    Acta Oncol; 2012 Jul; 51(6):713-21. PubMed ID: 22731832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Herceptin monotherapy in HER2(+) recurrent breast carcinoma].
    Eidtmann H
    Onkologie; 2002 Dec; 25 Suppl 5():14-5. PubMed ID: 23573613
    [No Abstract]   [Full Text] [Related]  

  • 18. [Multiple cutaneous plasmocytoma treated with topical applications of miltefosine].
    Viseux V; Schoenlaub P; Danhier S; Vilque JP; Plantin P
    Ann Dermatol Venereol; 2004 Feb; 131(2):204-5. PubMed ID: 15026752
    [No Abstract]   [Full Text] [Related]  

  • 19. Results of a phase II study of pemetrexed as first-line chemotherapy in patients with advanced or metastatic breast cancer.
    Robert NJ; Conkling PR; O'Rourke MA; Kuefler PR; McIntyre KJ; Zhan F; Asmar L; Wang Y; Shonukan OO; O'Shaughnessy JA
    Breast Cancer Res Treat; 2011 Feb; 126(1):101-8. PubMed ID: 21188632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combination therapy of local tumour recurrence in patients with breast cancer (author's transl)].
    Szepesi T; Sabitzer H; Sabitzer G
    Wien Klin Wochenschr; 1979 Jan; 91(1):15-8. PubMed ID: 425521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.